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Abstract. Functional dyspepsia (FD) is a non-organic gastro-
intestinal disorder that has a marked negative impact on quality 
of life. Compared with conventional pharmacological thera-
pies, the traditional Chinese medicine weikangning (WKN) 
is a safe and effective treatment for FD. The present study 
aimed to determine the molecular mechanisms underlying 
the efficacy of WKN. The effect of different concentrations 
of WKN on the proliferation of the human gastric mucosal 
epithelial cell line GES-1 was assessed. The optimal WKN 
concentration to promote cell proliferation was determined, 
and this concentration was used to examine the effect of WKN 
compared with a domperidone-treated positive control group 
on the antioxidant capacity of GES-1 cells. The effect of WKN 
treatment on the growth and antioxidant activity of GES-1 cells 
was also assessed following nuclear factor erythroid 2 like 2 
(Nrf2) knockdown. The optimal WKN dose for promoting cell 
growth was determined to be 0.025 mg/ml; at this concentra-
tion the expression of the antioxidant proteins glutathione 
S-transferase P and superoxide dismutase 2 (SOD2) were 
significantly elevated (P<0.0001). Furthermore, the amount of 
reduced glutathione and activity of SOD2 were significantly 
increased (P<0.0001 and P<0.01, respectively), and malondi-
aldehyde content was significantly decreased, compared with 
the controls (P<0.001). With WKN treatment, the transcription 
of Nrf2 and its downstream genes were significantly upregu-
lated (P<0.01), and the level and nuclear distribution of 
Nrf2 protein was also markedly increased. Following Nrf2 
silencing, the protective antioxidant effects of WKN treat-
ment were impaired and GES-1 cell proliferation decreased. 
The results of the present study suggest that the efficacy of 
WKN in protecting gastric mucosal epithelial cells in FD is 
antioxidant-dependent and mediated by Nrf2 activation.
Introduction
Functional dyspepsia (FD) is a non-organic gastrointestinal 
(GI) disorder with persistent or recurrent sensations of early 
satiety, post-prandial fullness, nausea, and pain or discomfort 
in the upper abdomen (1,2). According to recent statistics, 
FD affects 5-11% of the population worldwide (3). Although 
FD is not a life-threatening disease, it necessitates numerous 
medical treatments and places a significant economic burden 
on patients (4). Furthermore, it has been reported that FD may 
develop into peptic ulceration (5).
Uncovering the pathogenesis of FD may contribute to the 
development of successful intervention strategies, which may 
in turn prevent symptomatic exacerbations of the disease and 
potentially even restore the digestive system to normal. There 
are a number of theories regarding the potential causes of FD, 
including genetic factors, infection with Helicobacter pylori, 
neurologic-hormonal disorders, autonomic disorders, stress 
and mental disorders, visceral hypersensitivity, and altered 
duodenal sensitivity to acids and lipids (1).
Several studies have explored the potential causes of 
FD, and efforts have been made to identify effective treat-
ments; however, the optimal therapy for FD is yet to be 
determined (6). The majority of pharmacologic treatments 
that are currently available for FD have demonstrated limited 
efficacy (7). Several 5-hydroxytryptamine agonists, including 
tegaserod, cisapride, mosapride, pukabili, and renzapride, 
have demonstrated excellent efficacy in the treatment of FD 
via regulating GI dynamics; however, their safety has not been 
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adequately demonstrated (8). For example, evidence indicates 
that tegaserod may increase the risk of myocardial infarction, 
sudden cardiac death and other cardiovascular events (9,10). 
By contrast, cisapride may lead to QT interval prolongation, 
ventricular tachycardia and cardiac arrest (11).
The traditional Chinese medicine (TCM) weikangning 
(WKN) is a representative formula based on the classical 
TCM theory of ‘Xi Kai Ku Jiang’ (12). Several studies from 
the past decade have reported that WKN is a safe and effec-
tive treatment for FD (12,13). The composition of WKN 
includes the following nine Chinese herbs: Radix Scutellariae, 
Rhizoma Zingiberis, Radix Codonopsis pilosulae, Rheum 
rhabarbarum, Radix Bupleuri, Radix Curcumae, Magnolia 
off icinalis bark, Radix Paeoniae alba, and Rhizoma 
Corydalis (12). Pharmacological studies have indicated that 
Pinellia spp., Radix Codonopsis pilosulae, Villosum spp., 
Magnolia officinalis and Rheum rhabarbarum may strengthen 
GI smooth muscle tension (14-19). Furthermore, Scutellaria 
baicalensis and Coptis chinensis have been reported to func-
tion as anti-inflammatory and antiallergic mediators, and 
serve a dual-directional role in the regulation of GI smooth 
muscle, which may provide a pharmacological basis for WKN 
as a treatment for FD (20-22).
To learn more about the detailed molecular mechanism 
underlying the efficacy of WKN in the treatment of FD, our 
group previously conducted a proteomic study to identify the 
differences in GI protein expression in an FD rat model with 
and without WKN treatment (12). The results revealed that 
the protein expression levels of glutathione-S-transferase P 
(GSTP1) and superoxide dismutase 2 (SOD2) were decreased 
in the disease model group compared with the normal control 
group. However, following the administration of WKN, the 
expression of GSTP1 and SOD2 was enhanced.
According to previous studies, GSTP1 and SOD2 serve 
an important role in combating oxidative stress (23,24). For 
example, Wang et al (23) demonstrated that upregulating 
the expression of GSTP1 and SOD2 significantly decreased 
oxidative stress by reducing reactive oxygen species (ROS) 
formation. In addition, a study by Dato et al (24) reported 
that genes belonging to pro-antioxidant signaling pathways, 
including GSTP1 and SOD2, were positively associated 
with longevity and functional status in very old age. Based 
on such observations and preliminary work by our group, it 
was hypothesized that oxidative stress may be an important 
component of the pathological mechanism of FD and that 
the efficacy of WKN may be due to reduced levels of oxida-
tive stress. The results of these previous studies suggest that 
WKN may protect human GI cells by increasing antioxidant 
capacity, thereby maintaining the survival and growth of these 
cells and promoting recovery from FD. In addition, a previous 
study revealed that Nrf2 pathway played a critical role in 
antioxidation, anti-inflammation and protecting liver from 
oxidative damages in dyspepsia (25). Based on these results, it 
was investigated in the current study whether the antioxidant 
regulation of Nrf2, GSTP1 and SOD2 was involved underlying 
the WKN treatment for FD. Overall, the present study aimed 
to provide a theoretical basis for the use of TCMs in the treat-
ment and prevention of FD, and to provide experimental data 
to support the hypothesis that oxidative injury is important in 
the development and exacerbation of FD.
Materials and methods
Cell culture. The human gastric mucosal epithelial cell 
line GES-1 was purchased from the cell bank of Culture 
Preservation Committee, Chinese Academy of Sciences 
(Beijing, China). GES-1 cells were cultured in RPMI-1640 
medium (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, 
USA) containing 10% heat inactivated fetal bovine serum 
(Zhejiang Tianhang Biological Technology Co., Ltd., Zhejiang, 
China), 100,000 U/l penicillin and 100 mg/l streptomycin in 
an atmosphere containing 5% CO2 at 37˚C.
Establishment of the lentivirus‑mediated nuclear factor 
erythroid 2 like 2 (Nrf2) gene‑knockdown stable strain of 
GES‑1 cells. Four pairs of short hairpin (sh)RNA species 
targeting Nrf2 mRNA were designed by Origene Technologies 
(Rockville, MD, USA; Table I) and cloned into Lenti-KD 
vectors (Pre-1102; Beijing Pregene Science and Technology 
Co., Ltd., Beijing, China) with blank vectors as controls. Using 
Lipofectamine® 2,000 Transfection reagent (Thermo Fisher 
Scientific, Inc.), these plasmids, along with the pMD2.0G 
and psPAX2 plasmids (both Addgene, Cambridge, MA, 
USA), were successively transfected into 293T cells (ATCC, 
Manassas, VA, USA) to form a virus package. After each type 
of transfected 293T cells were cultured in 5% CO2 at 37˚C 
for 3 days, a 2 ml culture of supernatant-containing lentiviral 
particles was harvested by centrifugation at a speed of 300 x g 
at 4˚C for 5 min, and stored at ‑80˚C until required.
A total of 2x105 GES-1 cells were seeded into a 6-well 
plate. Following overnight culture, the adherent cells were 
transfected at room temperature with the lentivirus-containing 
culture medium overnight, and cultured at 30˚C in a 5% CO2 
incubator. The following day, the medium was replaced. At 
48-72 h following transfection, 3 µg/ml puromycin was added 
for selection and the cells were sub-cultured in a 10 cm2 plate, 
with continued puromycin treatment. The Nrf2 expression 
of transduced cells was identified using western blotting as 
described below.
The gene knockdown mediated by the lentivirus with the 
shNrf2-3 sequence appeared to be the most effective (Fig. 1). 
The GES-1 cell strain transfected with this lentivirus was cryo-
preserved at ‑80˚C as the Nrf2 gene‑knockdown stable strain, 
which is referred to as shNrf2 throughout the present study. 
At the same time, the GES-1 cells transfected with lentivirus 
containing shMock sequence (CCT AAG GTT AAG TCG CCC 
TCG) were cryopreserved and used as a control (shMock). 
After recovery, the culture conditions for the stable cell lines 
were the same as those described for the GES-1 cells above.
Drug preparation. WKN was prepared using the following 
ingredients: Rhizome Pinelliae Preparata, 9 g; Rhizoma 
Coptidis, 5 g; Radix Scutellariae, 9 g; Fructus Amomi villosi, 
6 g; Rhizoma Zingiberis, 9 g; Radix C. pilosulae, 15 g; Radix 
Curcumae, 9 g; M. officinalis bark, 9 g; Rhizoma Corydalis 
vinegar, 10 g; Radix Bupleuri, 9 g; rhubarb, 6 g; fried almond, 
9 g; inflammatory licorice, 9 g; Radix Paeoniae Alba, 15 g; and 
Fructus Ziziphi jujubae, 4 g. All components were supplied by 
the Department of Pharmacy of Wangjing Hospital of China 
Academy of Chinese Medical Sciences (Beijing, China). WKN 
was decocted according to traditional methods. The WKN was 
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immersed in water for 30 min, then 500 ml water was added and 
decocted for 30 min; the extract of ~150 ml was poured out, and 
another 500 ml water was added followed by decocting again; 
finally the extract of the two steps were mixed, at a total volume 
of 300 ml. The solution was condensed to a volume of 400 ml. 
The 400 ml crude extract solution was vacuum lyophilized for 
at least 3 h to obtain a powder using a freeze dryer (ALPHA1-4, 
Martin Christ GmbH, Osterode, Germany). The powder was 
stored until use at ‑20˚C, and was dissolved in PBS to make the 
stock solution (10 mg/ml). The stock solution was sterilized using 
60Co-γ radiation (26) and centrifuged at 15,000 x g, 37˚C for 
20 min to remove the insoluble ingredients. The stock solution 
was stored at ‑20˚C and diluted to varying degrees depending 
on the concentration required for the different experimental 
procedures.
Domperidone (Sigma-Aldrich; Merck KGaA, Darmstadt, 
Germany) was dissolved in dimethyl sulfoxide (Sigma-Aldrich; 
Merck KGaA) to create a stock solution (0.1 mol/l) and a 
working solution (2.5 µmol/ml), and was used as a positive 
control. PBS was used as the negative control. The drug treat-
ment groups varied depending on the different experimental 
procedures, as outlined below.
Proliferation activity assays
Cell Counting Kit‑8 (CCK‑8) assay. A total of 1x104 GES-1 
cells/well were seeded into a 96-well plate. The cells were 
then cultured in an atmosphere containing 5% CO2 at 37˚C 
for 4-6 h. Drug treatments were administered following adher-
ence. Cells were divided into 10 groups and WKN was added 
at different concentrations (0, 0.025, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 
0.6 and 0.7 mg/ml). After 12, 24 and 48 h of incubation at 37˚C, 
20 µl CCK-8 solution (Beyotime Institute of Biotechnology, 
Haimen, China) was added to the wells. Cells were then 
cultured at 37˚C for 1 h. Optical density was measured at 
450 nm using a microplate reader (POLARstar® Omega; BMG 
Labtech GmbH, Ortenburg, Germany). Four replicates were 
performed at each time-point for each group.
MTS assay. A total of 5x104 shMock or shNrf2 cells/well 
were seeded into a 96-well plate. The cells were then cultured 
with 5% CO2 at 37˚C for 4‑6 h. The drug treatment was 
performed following adherence. Cell culture media containing 
0.025 mg/ml WKN or equivalent amounts of PBS (as a blank 
control) was added to the wells. After 4, 48 and 96 h of 
incubation, 20 µl MTS solution (Beijing Pregene Science and 
Technology Co., Ltd., Beijing, China) was added to the wells. 
Cells were then cultured at 37˚C for 1 h. Optical density was 
measured at 490 nm using the microlate reader. Six replicates 
were performed at each time point for each group.
Reverse transcription‑quantitative polymerase chain reaction 
(RT‑qPCR) analysis. A total of 1.5x106 cells/well were seeded 
into a 6‑well plate. The cells were cultured with 5% at 37˚C 
for 4‑6 h. The drug treatments (see the corresponding figure 
legend for the specific group settings and processing times) 
were performed following adherence. After treatment, total 
RNA was extracted using TRIzol reagent (Thermo Fisher 
Scientific, Inc.) and RT was performed using a Prime Script™ 
RT reagent kit (Takara Bio, Inc., Shiga, Japan) according to 
the manufacturer's protocol. PCR primers were synthesized by 
Shanghai Biotech Co., Ltd. (Shanghai, China) and are listed in 
Table II. The reaction was kept on ice in the dark until qPCR 
was performed and was comprised of the following compo-
nents: 10 µl 2X SYBR Premix Ex Taq™ (Takara Bio, Inc.), 
0.5 µl PCR forward primer (10 µM), 0.5 µl PCR reverse primer 
(10 µM), 2 µl cDNA template and 7 µl distilled H2O. The ther-
mocycling conditions were as follows: Initial denaturation at 
95˚C for 1 min; 40 cycles of 95˚C for 15 sec, 60˚C for 15 sec 
and 72˚C for 45 sec; and a final extension at 72˚C for 5 min. 
Relative mRNA expression was calculated using the 2-∆∆Cq 
method (27). β-actin was used as the internal reference gene.
Western blotting. A total of 1.5x106 cells/well were seeded into 
a 6-well plate and cultured with 5% CO2 at 37˚C for 4‑6 h. 
Table I. Sequences of shRNAs targeting Nrf2 mRNA.
Oligo Sequence
shNrf2-1 F: 5'-GATCCGCACCTTATATCTCGAAGTTTCTTCCTGTCAGAAAACTTCGAGATATAAGGTGCTTTTTG-3'
 R: 5'-AATTCAAAAAGCACCTTATATCTCGAAGTTTTCTGACAGGAAGAAACTTCGAGATATAAGGTGCG-3'
shNrf2-2 F: 5'-GATCCCCGGCATTTCACTAAACACAACTTCCTGTCAGATTGTGTTTAGTGAAATGCCGGTTTTTG-3'
 R: 5'-AATTCAAAAACCGGCATTTCACTAAACACAATCTGACAGGAAGTTGTGTTTAGTGAAATGCCGGG-3'
shNrf2-3 F: 5'-GATCCCCCTGTTGATTTAGACGGTATCTTCCTGTCAGAATACCGTCTAAATCAACAGGGTTTTTG-3'
 R: 5'-AATTCAAAAACCCTGTTGATTTAGACGGTATTCTGACAGGAAGATACCGTCTAAATCAACAGGGG-3'
shNrf2-4 F: 5'-GATCCGCAGCAAACAAGAGATGGCAACTTCCTGTCAGATTGCCATCTCTTGTTTGCTGCTTTTTG-3'
 R: 5'-AATTCAAAAAGCAGCAAACAAGAGATGGCAATCTGACAGGAAGTTGCCATCTCTTGTTTGCTGCG-3'
shRNA, short hairpin RNA; Nrf2, nuclear factor erythroid 2 like 2; F, forward; R, reverse.
Figure 1. Expression of Nrf2 protein in GES-1 cell strains transfected with 
four types of shRNA or control shRNA. The expression of Nrf2 protein was 
assessed by western blotting. shRNA, short hairpin RNA; Nrf2, Nrf nuclear 
factor erythroid 2 like 2.
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Drug treatments (see the corresponding figure legend for the 
specific group settings and processing times) were adminis-
tered following adherence. Total protein was extracted when 
cells were collected. After ultrasonic homogenization in the 
RIPA lysis buffer (150 µl; Applygen Technologies, Inc., Beijing, 
China), cells were lysed at 4˚C for another 10 min, centrifuged 
(15,000 x g, 4˚C, 15 min), and the supernatant was transferred 
for analysis. Then protein was quantified using a BCA Protein 
Quantification kit (Beijing Biomed Biological Technology 
Co., Ltd., Beijing, China). Protein was denatured at 100˚C for 
5 min, and 20-40 µg of protein samples were loaded Next, 
SDS-PAGE was performed using the following settings: 4% 
stacking gel, 80 V for 30 min; and a 12% resolving gel, 120 V 
for 1 h. Proteins were then electrotransferred onto PVDF 
membranes. The membranes were blocked with 5% nonfat 
milk in Tris-buffered saline (pH 7.5) with 0.1% Tween-20 
for 1 h at room temperature. Primary antibodies directed 
against the following proteins were used: GSTP1 (P04906, 
Enzo Life Sciences, Farmingdale, NY, USA; 1:1,000), SOD2 
(2299-1, Epitomics; Abcam, Cambridge, UK; 1:1,000), 
Nrf2 (ab62352, Abcam; 1:1,000), and β-actin (4970S, rabbit 
monoclonal antibody; Cell Signaling Technology, Danvers, 
MA, USA; 1:5,000). The membrane was incubated with the 
primary antibodies at 4˚C overnight. The secondary horse-
radish peroxidase-conjugated immunoglobulin G antibody 
(ZB-2301; 1:3,000) was purchased from Zhongshan Jinqiao 
Biotechnology Co., Ltd. (Beijing, China). The membrane was 
incubated with the secondary antibodies at room temperature 
for 1 h. Protein bands were visualized using an enhanced elec-
trochemiluminescence western blot high-sensitivity detection 
kit (CW0049 M, Beijing Comwin Biotech Co., Ltd., Beijing, 
China) and images were captured using the Gel Doc™ XR 
Gel Imaging system (Bio-Rad Laboratories, Inc., Hercules, 
CA, USA). Semi-quantitative analysis was performed using 
ImageJ 1.47 software (National Institutes of Health, Bethesda, 
MA, USA). The results are presented as percentages relative to 
the control groups.
Immunofluorescent staining. GES-1 cells were seeded into 
a culture dish with pretreated coverslips at a density of 105 
cells/500 µl. After adherence, 0.025 mg/ml WKN was added 
to the experimental groups, while an equivalent amount of 
PBS was added to the control group. After 24 h of treatment 
at 37˚C, the cells were harvested. The slides were soaked 
in PBS 3 times (3 min/soak) and fixed at room temperature 
for 15 min using 4% paraformaldehyde. Slides were subse-
quently soaked in PBS 3 times (3 min/soak) and penetrated 
with 0.5% Triton X-100 (in PBS) for 20 min at room tempera-
ture. Next, the slides were soaked in PBS and blotted dry. 
Subsequently, the slides were blocked with 6% normal goat 
serum (HyClone; GE Healthcare Life Sciences, Logan, UT, 
USA) in PBS for 20 min at room temperature. The blocking 
solution was removed and the slides were treated with primary 
antibodies directed against Nrf2 (ab137550, Abcam; 1:40) 
overnight at 4˚C. The slides were then rewarmed at 37˚C for 
45 min, soaked in PBS 3 times (3 min/soak) and blotted dry. 
A fluorescent secondary antibody, goat anti‑rabbit IgG H&L 
Alexa Fluor® 647 (ab150079; Abcam; 1:800), was added 
and the slides were incubated for 30 min at 37˚C. The slides 
were soaked in PBS 3 times (3 min/soak) and blotted dry. 
The slides were treated with DAPI dye (Beyotime Institute 
of Biotechnology) at room temperature in the dark for 5 min 
to stain the cell nuclei. The slides were then washed with 
PBS 4 times (5 min/wash), sealed with mounting medium 
containing anti‑fluorescence quenching reagent (Antifade 
Mounting Medium; Beyotime Institute of Biotechnology) 
and the edges were sealed with nail polish. The slides were 
observed under a fluorescence microscope and representative 
images were captured.
Detection of oxidative stress levels. Cells were lysed 
following drug treatment (see the corresponding figure legend 
for the specific group settings and processing times). The 
culture medium was removed and the cells were rinsed with 
pre-cooled PBS twice. Pre-cooled PBS (1 ml) was added and 
cells were swept with a cell lifter, then transferred into a 1.5 ml 
microcentrifuge tube. Centrifugation was performed at 4˚C 
and at 650 x g for 15 min. The sediment was harvested and 
cytopreserved at ‑80˚C. Different aspects of oxidative stress 
were detected using a reduced glutathione (GSH) content 
assay kit [intra-assay coefficient of variation (CV), 1.2%; 
inter-assay CV: 3.86%; sensitivity, 0.3-147.1 mg/l], a SOD 
enzyme activity assay kit (intra-assay CV, 5.05%; inter-assay 
CV, 3.32%; sensitivity, 0.5 U/ml), and a maleic dialdehyde 
(MDA) content assay kit (intra-assay CV, 3.5%; inter-assay CV, 
4.11%; sensitivity, 0.5-113 nmol/ml). All kits were provided by 
Nanjing Jiancheng Bioengineering Institute (Nanjing, China). 
Cell lysis, the detection procedure and result calculations were 
all performed according to the manufacturer's protocol.
Table II. Primers used in reverse transcription-quantitative 
polymerase chain reaction.
Target 
gene Sequence
GSTP1 F: 5'-GGCTCTATGGGAAGGACCAGC-3'
 R: 5'-CACATAGTCATCCTTGCCCGCC-3'
SOD2 F: 5'-TCAGCCCTAACGGTGGTGGA-3'
 R: 5'-AAGCCAACCCCAACCTGAGC-3'
Nrf2 F: 5'-AGCATGCTACGTGATGAAGATGG-3'
 R: 5'-AGCTCAGAAAAGGTCAAATCCTCC-3'
NQO1 F: 5'-CATCCCAACTGACAACCAGAT-3'
 R: 5'-CAGGGAAGCCTGGAAAGATAC-3'
HO-1 F: 5'-ATGACACCAAGGACCAGAGC-3'
 R: 5'-GCATAAAGCCCTACAGCAACT-3'
GCLM F: 5'-CACGAGGTCAGGAGTTTGAGA-3'
 R: 5'-AGCTGAGATTACAGGCGAGTG-3'
GCLC F: 5'-CCCTCCTCCAAACTCAGACAT-3'
 R: 5'-TGGTGAGCAGTACCACAAACA-3'
β-actin F: 5'-GCTGCCCTGAGGCACTCTTC-3'
 R: 5'-ATCCTGTCGGCAATGCCAGG-3'
GSTP1, glutathione-S-transferase P; SOD2, superoxide dismutase 2; 
Nrf2, nuclear factor erythroid 2 like 2; NQO1, NADPH dehydroge-
nase quninone 1; HO, heme oxygenase; GCLM, glutamate cystteine 
ligase modifier subunit; GCLC, glutamate cysteine ligase catalytic 
subunit; F, forward; R, reverse.
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Statistical analysis. All experiments were repeated 
≥3 times, and the results were analyzed using SPSS software 
(version 19.0; IBM Corp., Armonk, NY, USA). Data are repre-
sented as the mean ± standard deviation. Student's t-test was 
used to analyze differences between two groups. P<0.05 was 
considered to indicate a statistically significant difference.
Results
Low concentrations of WKN promote GES‑1 cell proliferation. 
A CCK-8 assay was used to investigate cell proliferation and it 
was demonstrated that WKN at lower concentrations had the 
optimal effect in promoting the proliferation of GES-1 cells at 
all time points (Fig. 2). The pro-proliferative effects gradually 
weakened with an increase in the concentration of WKN. The 
optimal effect was observed at 0.025 mg/ml.
Low concentrations of WKN increase the expression of 
GSTP1 and SOD2 in GES‑1 cells. In our previous study 
of WKN treatment in FD model rats, proteomics were 
analyzed, and it was demonstrated that GSTP1 and SOD2 
expression levels were decreased in the disease model group 
and upregulated following WKN treatment (12). It was there-
fore speculated that the growth-promoting effect of WKN 
treatment on GES-1 cells may be associated with the expres-
sion of GSTP1 and SOD2. Therefore, in the present study 
changes in GSTP1 and SOD2 expression following WKN 
treatment were investigated. Following treatment with WKN 
at different concentrations for 24 h, the expression level of 
GSTP1 mRNA in GES-1 cells was significantly elevated 
compared with the control group (P<0.05; Fig. 3A). However, 
no significant difference was observed between the domperi-
done treatment group and the control group (Fig. 3A). 
Although domperidone treatment significantly enhanced 
SOD2 mRNA levels (P<0.05; Fig. 3A), and GSTP1 and SOD2 
protein levels (P<0.0001 and P<0.001, respectively; Fig. 3B), 
compared with the control group, 0.025 mg/ml WKN had 
a greater effect (P<0.0001; Fig. 3B). As the concentration 
of WKN increased, its effect on GSTP1 and SOD2 mRNA 
and protein levels decreased (Fig. 3). These results further 
confirmed that the efficacy of WKN is concentration‑depen-
dent. When the concentration of WKN was 0.025 mg/ml, the 
protective effect on GES-1 cells of promoting cell growth, 
and increasing GSTP1 and SOD2 expression levels, was the 
greatest. Therefore, this was chosen as the optimal concen-
tration for subsequent experiments.
WKN decreases oxidative stress in GES‑1 cells. GSTP1 and 
SOD2 serve important roles in combating oxidative stress. It 
was therefore hypothesized that the growth-promoting effect 
of WKN on gastric mucosal epithelial cells was associated 
with the regulation of oxidative stress. The GSH content, SOD 
activity and MDA content were measured as a proxy for the 
level of cellular oxidative stress (Fig. 4). When GES-1 cells 
were treated with 0.025 mg/ml WKN, GSH content and SOD 
activity increased significantly (P<0.0001 and P<0.01, respec-
tively), while MDA content decreased significantly (P<0.001), 
compared with the control group. However, no significant 
changes in oxidative stress index levels were observed in the 
domperidone treatment group.
WKN increases the expression of Nrf2 and its target genes 
in GES‑1 cells. A previous study identified gstp1 and sod2 
as two of the putative Nrf2-dependent genes (27) and Nrf2 
has been identified as an important transcription factor that 
regulates oxidative stress (28-32). To determine whether WKN 
treatment enhanced the antioxidant capacity of cells via the 
promotion of Nrf2, GES-1 cells were treated with 0.025 mg/ml 
WKN and the expression level of the Nrf2 gene was measured 
as the processing time increased. The transcription level of 
Nrf2 was significantly upregulated following 2 h of WKN 
treatment (P<0.001; Fig. 5A). This effect decreased with time. 
The transcription levels of four target genes of Nrf2 (NADPH 
dehydrogenase quninone 1, heme oxygenase 1, glutamate 
cysteine ligase modifier subunit and glutamate cysteine ligase 
catalytic subunit) were measured after 2 h (data not shown) and 
4 h (Fig. 5B) of treatment with 0.025 mg/ml WKN. The results 
demonstrated that the transcription of the four genes increased 
significantly following 4 h of treatment (P<0.01; Fig. 5B).
WKN increases GES‑1 cell Nrf2 content and nuclear trans‑
location. Under normal conditions, Nrf2 is anchored in the 
cytoplasm by Kelch-like ECH-associated protein 1 (Keap1). 
However, when cells are exposed to inducing stimuli, Nrf2 
is activated, released from Keap1 and transported into the 
nucleus (33). Nrf2 then combines with the antioxidant response 
element (ARE) in the promoter region of downstream target 
genes, activating the transcription of target genes and trans-
ducing antioxidant signals (34). To clarify the impact of WKN 
treatment on Nrf2 transcriptional activity, changes in Nrf2 
content and nuclear localization after WKN treatment were 
assessed in the present study. Immunofluorescence staining 
revealed that the Nrf2 content of cells was markedly increased 
following WKN treatment and that Nrf2 protein was translo-
cated into the nucleus (Fig. 5C).
Nrf2 silencing inhibits the protective effect of WKN on 
GES‑1 cells. To further confirm that the growth‑promoting 
effect of WKN on gastric mucosa epithelial cells was via 
the upregulation of Nrf2 and associated signaling pathways, 
a lentiviral-mediated Nrf2 gene knockdown GES-1 cell line 
was established. Western blotting revealed that Nrf2 protein 
expression decreased most markedly in shNrf22-3 silenced 
Figure 2. Proliferation GES-1 cells after 12, 24 or 48 h of WKN treatment 
at different concentrations (0, 0.025, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6 and 
0.7 mg/ml) detected using the Cell Counting Kit-8 assay. WKN, weikangning.
CHANG et al:  MUCOSAL EPITHELIAL CELLS AND Nrf22890
cells compared with the shMock cells (Fig. 1). Thus, these 
shNrf cells were taken forward for further experiments.
In the shMock cells, treatment with 0.025 mg/ml WKN 
significantly increased the mRNA and protein expression of 
GSTP1 and SOD2 compared with the control group (P<0.05; 
Fig. 6A and B). In shNrf2 cells, the mRNA and protein 
expression of GSTP1 and SOD2 were significantly lower 
compared with the shMock cells, before and after WKN treat-
ment (P<0.01; Fig. 6A and B). Furthermore, when Nrf2 was 
knocked down, the GSH content and SOD activity of GES-1 
cells decreased significantly, and MDA increased significantly, 
compared with the shMock group (P<0.001; Fig. 6C-E), 
despite treatment with WKN. These results indicate that the 
protective effect of WKN against cellular oxidative stress was 
significantly impaired by Nrf2 silencing.
The proliferative abilities of shNrf2 and shMock cells 
were examined using the MTS assay following 4, 48 and 
96 h of treatment with 0.025 mg/ml WKN (Fig. 6F). This 
demonstrated that 48 h of WKN treatment promoted the 
proliferation of shMock cells, but this effect decreased 
over time. Under Nrf2 silencing conditions, GES-1 cell 
growth was slower (P<0.0001; cont rol + shNrf2 
vs. control + shMock group). Furthermore, with Nrf2 
knockdown, the effect of 48 h WKN treatment cell 
Figure 4. GSH content, SOD activity and MDA content of GES-1 cells following 24 h treatment with 2.5 µmol/ml DD or 0.025 mg/ml WKN. GES-1 cells 
treated with PBS solution were used as the control group. **P<0.01 and ****P<0.0001 vs. the control group. GSH, glutathione; SOD, superoxide dismutase; MDA, 
maleic dialdehyde; WKN, weikangning; DD, domperidone.
Figure 3. WKN treatment increases the expression of GSTP1 and SOD2 in GES-1 cells. GSTP1 and SOD2 (A) mRNA and (B) protein levels in GES-1 cells 
after 24 h treatment with 2.5 µmol/ml DD or WKN at. GES-1 cells treated with PBS were used as the control group and all results were normalized to the 
control. *P<0.05, ***P<0.001 and ****P<0.0001 vs. the control group. ∆∆∆P<0.001 and ∆∆∆∆P<0.0001 vs. the DD group. #P<0.05, ###P<0.001 and ####P<0.0001 
vs. the 0.025 mg/ml WKN group. WKN, weikangning; GSTP1, glutathione-S-transferase P; SOD2, superoxide dismutase 2; DD, domperidone.
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proliferation was significantly reduced (P<0.0001; 
WKN + shNrf2 vs. WKN +  shMock group).
Discussion
In a previous study, our group investigated the pathogenesis 
of FD, in addition to the therapeutic effect of WKN and the 
underlying molecular mechanism of this effect, from the 
perspective of proteomic analysis in a rat model of FD (12). 
It was demonstrated that the expression levels of GSTP1 and 
SOD2 were significantly upregulated in the WKN treatment 
group compared with the disease model group.
GSH-dependent and SOD enzymes are important cellular 
antioxidants that serve vital roles in resisting the damaging 
effects of external toxin and ROS (35,36). GSTP1 is a member 
of the GSTP family, a subtype of GSTs. GSTP1 is capable of 
catalyzing the conjugate connections between GSH and charged 
complexes, so as to serve the function of detoxification. A 
previous study reported that different genotypes of the GSTP1 
exon 5 are associated with intestinal metaplasia in the pre-gastric 
cancer stage, and positively interact with Helicobacter pylori 
infection in the intestinal metaplasia (37). SOD2 is primarily 
sub-cellularly located in the mitochondria and is an important 
component of the cellular antioxidant system (38-40). SOD2 
maintains the balance between oxidation and antioxidation by 
reducing superoxides, including the superoxide anion (36). It 
has previously been reported that SOD2 knockout may be lethal 
in animals (41), whereas SOD2 overexpression significantly 
reduces lipid peroxidation, represses protein nitrosylation of 
protein tyrosine residues, inhibits cellular apoptosis and amelio-
rates ischemic tissue injury (42). In addition, SOD2 is able to 
inhibit the activation of the mitochondrial-dependent apoptotic 
signaling pathway by inhibiting the transfer of cytochrome 
c from mitochondria to the cytoplasm (43-45). There is also 
evidence that SOD2 serves a more important role than SOD1 in 
cellular resistance to stress and injury (46).
Figure 5. WKN treatment increases the transcription of Nrf2 in GES-1 cells. Transcription of (A) Nrf2 following 0.025 mg/ml WKN treatment for 0.5, 2, 4 and 
8 h, and (B) Nrf2 downstream target genes, GCLC, HO-1, GCLM and NQO1 in GES-1 cells following 0.025 mg/ml WKN treatment for 4 h. The results were 
normalized to the PBS control. (C) Representative immunofluorescence images of Nrf2 staining in GES‑1 cells after 24 h treatment with 0.025 mg/ml WKN 
or PBS solution. White stars indicate accumulated Nrf2 in the cytoplasm and white arrows indicate translocated Nrf2 in the nucleus. Magnification, x800. 
*P<0.05, **P<0.01, ***P<0.001 and ****P<0.0001 vs. the control group. WKN, weikangning; Nrf2, nuclear factor erythroid 2 like 2; GCLC, glutamate cysteine 
ligase catalytic subunit; HO‑1, heme oxygenase 1; GCLM, glutamate cysteine ligase modifier subunit; NQO1, NADPH dehydrogenase quninone 1.
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Changes in the expression levels of GSTP1 and SOD2 in 
the FD rat model in our previous study suggested that oxidative 
stress may participate in the pathogenesis of FD (12). Previous 
studies have indicated that oxidative stress in GI tissues may 
serve an important role in the development of gastric damage 
and disorders, and the protective effects of certain pharmaco-
logical agents were reported to be associated with a reduction 
in oxidative stress (47-49). In the present study, SOD2 and 
GSTP1 were identified to be upregulated at the transcrip-
tional and protein levels in human mucosal epithelial cells 
after WKN treatment. Furthermore, the GSH content, SOD 
activity and MDA content measured in the WKN-treated cells 
indicated that the WKN decreased oxidative stress in gastric 
mucosal epithelial cells.
Figure 6. Nrf2 knockdown inhibits the protective effects of WKN on GES-1 cells. After 24 h treatment with 0.025 mg/ml WKN or PBS solution, the levels of 
expression of GSTP1 and SOD2 (A) mRNA and (B) protein, (C) GSH content, (D) SOD activity and (E) MDA content in shMock cells and shNrf2 cells were 
asessed. Results were normalized to the values of the control + shMock group. (F) Effect of 0.025 mg/ml WKN treatment on the growth of GES‑1 cells prior 
to and after Nrf2 knockdown was assessed using the MTT assay. *P<0.05, **P<0.01, ***P<0.001 and ****P<0.0001 vs. the control + shMock group. ##P<0.01, 
###P<0.001, ####P<0.0001 vs. the 0.025 mg/ml WKN + shMock group. Nrf2, nuclear factor erythroid 2 like 2; WKN, weikangning; GSTP1, glutathione‑S‑trans‑- - -
ferase P; SOD2, superoxide dismutase 2; GSH, glutathione; MDA, maleic dialdehyde; shRNA, short hairpin RNA.
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The results of the present study suggest that WKN promotes 
the expression and thus effects of antioxidant enzymes via the 
Nrf2/ARE signaling pathway, which was supported by the results 
of lentiviral-mediated Nrf2 knockdown. Nrf2 is an important 
transcription factor that exerts a protective effect against oxida-
tive and chemical stress, through regulating the expression of 
antioxidant proteins via ARE interaction (35). The Nrf2-ARE 
signaling pathway is the main pathway that induces cell resis-
tance to damage by exogenous substances and oxidative stress. 
Nrf2 also serves key roles in maintaining homeostasis of the cell 
microenvironment, and promoting cell growth and reproduc-
tion (50,51). Nrf2 is able to protect the lungs, liver and digestive 
tract without cell or organ specificity (52,53). Consequently, 
Nrf2 has great therapeutic potential for multi-organ protec-
tion (53,54). The results of the present study demonstrated 
that Nrf2 may serve an essential role in GES-1 cells, as Nrf2 
knockdown has an impact on growth and antioxidant activity. 
However, it remains to be elucidated whether the protective 
effect of WKN is entirely dependent on Nrf2 signaling.
In conclusion, combined with our previous research, 
the results of the present study suggest that the therapeutic 
efficacy of the TCM WKN as a treatment for FD relies on 
oxidative stress alleviation in GES-1 cells, which is mediated 
by Nrf2 signaling. The results of the present study also indi-
cate indirectly that oxidative stress may be associated with the 
pathogenesis and development of GI disorders, something that 
has been proposed previously but is lacking in evidence (55,56). 
The beneficial effects of TCMs on inflammatory GI diseases 
and associated tumorigenesis have been extensively studied, 
with certain reports suggesting that these treatments act via 
modulating the Nrf2 signaling pathway (57,58). Future studies 
should test the results of the present study using an in vivo 
model of FD to increase the understanding of the pathology of 
functional GI disorders and potentially provide a clinical basis 
for WKN as a treatment for FD.
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